The fusarium keratitis outbreak: not done yet?
Jeng
Bennie H
BH
The Cole Eye Institute, Cleveland Clinic, 9500 Euclid Ave, OH 4419, USA. jengb@ccf.org
Hall
Gerri S
GS
Schoenfield
Lynn
L
Meisler
David M
DM
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D003320:Corneal Ulcer / Q000453:epidemiology* / Q000382:microbiology / Q000628:therapy; D004196:Disease Outbreaks; D004359:Drug Therapy, Combination; D015821:Eye Infections, Fungal / Q000453:epidemiology* / Q000382:microbiology / Q000628:therapy; D005260:Female; D005670:Fusarium / Q000302:isolation & purification*; D006801:Humans; D015948:Keratoplasty, Penetrating; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000453:epidemiology* / Q000382:microbiology / Q000628:therapy; D010866:Natamycin / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D010866:Natamycin; D065819:Voriconazole